000			02938cmm a2200277 a 4500
001			46941
003			IN-BdCUP
005			20230426175607.0
008			230426s2023 u eng
020			_a9781315364537
040			_beng _cIN-BdCUP
041			_aeng
082			_a615.600 _bP823
245		0	_aPoorly soluble drugs : _bdissolution and drug release / _cedited by Gregory K. Webster, J. Derek Jackson, Robert G. Bell
260			_aSingapore : _bPan Stanford Publishing, _c[2017];©2017
300			_a1 online resource
505			_a1. The modern pharmaceutical development challenge : BCS class II and IV drugs / Gregory K. Webster, Robert G. Bell, and J. Derek Jackson -- 2. Solubility determinations for pharmaceutical API / Kofi Asare-Addo and Barbara R. Conway -- 3. Use of surfactants in dissolution testing / Amit Gupta -- 4. Intrinsic dissolution evaluation of poorly soluble drugs / Michele Georges Issa and Humberto Gomes Ferraz -- 5. Oral delivery of poorly soluble drugs / Dev Prasad, Akash Jain, and Sudhakar Garad -- 6. A staged approach to pharmaceutical dissolution testing / Gregory K. Webster, Xi Shao, and Paul D. Curry, Jr. -- 7. Development and application of in vitro two-phase dissolution method for poorly water-soluble drugs / Ping Gao, Yi Shi, and Jonathan M. Miller -- 8. The use of apparatus 3 in dissolution testing of poorly soluble drug formulations / G. Bryan Crist -- 9. Use of apparatus 4 in dissolution testing, including sparingly and poorly soluble drugs / Rajan Jog, Geoffrey N. Grove, and Diane J. Burgess -- 10. Dissolution of nanoparticle drug formulations / John Bullock -- 11. Dissolution of lipid-based drug formulations / Stephen M. Cafiero -- 12. Dissolution of stabilized amorphous drug formulations / Justin R. Hughey -- 13. Dissolution of pharmaceutical suspensions / Beverly Nickerson, Michele Xuemei Guo, Kenneth J. Norris, and Ling Zhang -- 14. Dissolution testing of poorly soluble drugs : biorelevant dissolution / Mark McAllister and Irena Tomaszewska -- 15. Clinically relevant dissolution for low-solubility immediate-release products / Paul A. Dickinson, Talia Flanagan, David Holt, and Paul W. Stott -- 16. The QbD approach to method development and validation for dissolution testing / Alger D. Salt -- 17. Regulatory considerations in dissolution and drug release of BCS class II and IV compounds / Robert G. Bell and Laila Kott -- 18. Dissolution of liquid-filled capsules based formulations / Rampurna Prasad Gullapalli -- 19. Current and emerging non-compendial methods for dissolution testing / Namita Tipnis and Diane J. Burgess
650			_aPharmacology
650			_aDrug delivery systems
650			_aPharmaceutical technology
700			_aWebster, Gregory K. _eEditor
700			_aJackson, J. Derek
700			_aBell, Robert G.
856			_3Electronic Book Resource _uhttps://www.taylorfrancis.com/books/9781315364537
942			_2ddc _cE
999			_c48951 _d48951